Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial-Reference-Cited by-同舟云学术

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

Published:2023-08 Issue:8 Volume:10 Page:e600-e611
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Xuan Li,Wang Yu,Yang Kaibo,Shao Ruoyang,Huang Fen,Fan Zhiping,Chi Peiru,Xu Yajing,Xu Na,Deng Lan,Li Xudong,Liang Xinquan,Luo Xiaodan,Shi Pengcheng,Liu Hui,Wang Zhixiang,Jiang Ling,Lin Ren,Chen Yan,Tu Sanfang,Zhang Yu,Sun Jing,Huang Xiaojun,Liu Qifa

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N Engl J Med,2016

2. Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

3. FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions;Antar;Leukemia,2020

4. Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial;Xuan;Lancet Oncol,2020

5. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation;Xuan;J Hematol Oncol,2021

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid Leukemia;Modern Pathology;2024-09

2. Ferroptosis-Related Gene Signature for Prognosis Prediction in Acute Myeloid Leukemia and Potential Therapeutic Options;International Journal of General Medicine;2024-09

3. Precision medicine in AML: overcoming resistance;International Journal of Hematology;2024-08-01

4. Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?;Expert Review of Hematology;2024-07-21

5. Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience;Frontiers in Oncology;2024-06-24